$MULN
MULLEN AUTOMOTIVE INC.

2023 Q4 Form 10-Q Financial Statement

#000155837024001064 Filed on February 13, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $58.00K
YoY Change
Cost Of Revenue $25.21K
YoY Change
Gross Profit $32.79K
YoY Change
Gross Profit Margin 56.53%
Selling, General & Admin $43.23M $67.27M
YoY Change -28.18% 202.73%
% of Gross Profit 205168.5%
Research & Development $16.17M $26.20M
YoY Change 87.54% 118.58%
% of Gross Profit 79897.38%
Depreciation & Amortization $4.344M $5.398M
YoY Change -9.39% 128.41%
% of Gross Profit 16463.25%
Operating Expenses $16.17M $97.86M
YoY Change -78.04% 185.66%
Operating Profit -$59.40M -$97.83M
YoY Change -19.31%
Interest Expense -$6.987M -$28.24M
YoY Change -97.67% -1054.89%
% of Operating Profit
Other Income/Expense, Net $545.4K $487.8K
YoY Change -15.55% -100.08%
Pretax Income -$65.72M -$210.3M
YoY Change -82.64% -65.62%
Income Tax -$1.726M -$10.47M
% Of Pretax Income
Net Earnings -$61.39M -$172.2M
YoY Change -83.68% -73.57%
Net Earnings / Revenue -296956.31%
Basic Earnings Per Share -$15.32
Diluted Earnings Per Share -$15.32 -$85.14
COMMON SHARES
Basic Shares Outstanding 4.008M 184.2M
Diluted Shares Outstanding 4.008M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.51M $155.3M
YoY Change 19.74% 187.08%
Cash & Equivalents $81.51M $155.3M
Short-Term Investments
Other Short-Term Assets $31.29M $25.38M
YoY Change -26.58% -21.28%
Inventory $30.72M $16.81M
Prepaid Expenses $6.687M $8.850M
Receivables $0.00 $671.8K
Other Receivables $0.00 $0.00
Total Short-Term Assets $143.5M $198.1M
YoY Change 5.88% 129.49%
LONG-TERM ASSETS
Property, Plant & Equipment $86.92M $82.03M
YoY Change -3.21% 454.14%
Goodwill $28.85M $28.85M
YoY Change -68.93% -68.92%
Intangibles $103.6M $104.2M
YoY Change -8.65% 10.4%
Long-Term Investments
YoY Change
Other Assets $2.187M $960.5K
YoY Change -35.48% -71.29%
Total Long-Term Assets $237.7M $223.6M
YoY Change -22.18% 3.38%
TOTAL ASSETS
Total Short-Term Assets $143.5M $198.1M
Total Long-Term Assets $237.7M $223.6M
Total Assets $381.2M $421.7M
YoY Change -13.56% 39.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.46M $13.18M
YoY Change 9.45% 105.92%
Accrued Expenses $38.17M $41.20M
YoY Change 513.03% 473.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.622M $7.461M
YoY Change -91.88% 93.48%
Total Short-Term Liabilities $96.44M $139.6M
YoY Change -75.74% 14.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $10.76M $5.395M
YoY Change 218.19% 60.59%
Total Long-Term Liabilities $10.76M $5.395M
YoY Change 119.98% 4.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $96.44M $139.6M
Total Long-Term Liabilities $10.76M $5.395M
Total Liabilities $109.4M $148.9M
YoY Change -73.97% 2.24%
SHAREHOLDERS EQUITY
Retained Earnings -$1.924B -$1.862B
YoY Change 51.92% 109.26%
Common Stock $5.885K $2.872K
YoY Change -99.65% -99.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $210.6M $209.0M
YoY Change
Total Liabilities & Shareholders Equity $381.2M $421.7M
YoY Change -13.56% 39.36%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$61.39M -$172.2M
YoY Change -83.68% -73.57%
Depreciation, Depletion And Amortization $4.344M $5.398M
YoY Change -9.39% 128.41%
Cash From Operating Activities -$59.90M -$65.54M
YoY Change 80.27% 190.33%
INVESTING ACTIVITIES
Capital Expenditures $6.866M $473.3K
YoY Change 845.06% -107.57%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.866M -$473.3K
YoY Change -92.67% -98.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -5.713M
YoY Change -100.0% -106.99%
NET CHANGE
Cash From Operating Activities -59.90M -65.54M
Cash From Investing Activities -6.866M -473.3K
Cash From Financing Activities 0.000 -5.713M
Net Change In Cash -66.76M -71.73M
YoY Change -389.57% -408.33%
FREE CASH FLOW
Cash From Operating Activities -$59.90M -$65.54M
Capital Expenditures $6.866M $473.3K
Free Cash Flow -$66.77M -$66.02M
YoY Change 96.63% 304.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001499961
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2871707
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5884691
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.04
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.04
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.11
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2022Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesCurrent
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2871707
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5884691
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
001-34887
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
MULLEN AUTOMOTIVE INC.
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3289406
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
1405 Pioneer Street
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Brea
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92821
CY2023Q4 dei City Area Code
CityAreaCode
714
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
613-1900
CY2023Q4 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001
CY2023Q4 dei Trading Symbol
TradingSymbol
MULN
CY2023Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6552470
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81512264
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155267098
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7426972
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
429372
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
671750
CY2023Q4 us-gaap Inventory Net
InventoryNet
30719529
CY2023Q3 us-gaap Inventory Net
InventoryNet
16807013
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23863455
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24955223
CY2023Q4 us-gaap Assets Current
AssetsCurrent
143522220
CY2023Q3 us-gaap Assets Current
AssetsCurrent
198130456
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86916241
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82032785
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
103569927
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
104235249
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
2733998
CY2023Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
2250489
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13400598
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5249417
CY2023Q4 us-gaap Goodwill
Goodwill
28846832
CY2023Q3 us-gaap Goodwill
Goodwill
28846832
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2186704
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
960502
CY2023Q4 us-gaap Assets
Assets
381176520
CY2023Q3 us-gaap Assets
Assets
421705730
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15458604
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13175504
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38166937
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41201929
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
423163
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
401859
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
20714620
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
64863309
CY2023Q4 muln Liability To Issue Shares Current
LiabilityToIssueSharesCurrent
11489068
CY2023Q3 muln Liability To Issue Shares Current
LiabilityToIssueSharesCurrent
9935950
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2137882
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2134494
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7622156
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
7461492
CY2023Q4 muln Refundable Deposit Current
RefundableDepositCurrent
426972
CY2023Q3 muln Refundable Deposit Current
RefundableDepositCurrent
429372
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
96439402
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
139610909
CY2023Q4 muln Liability To Issue Shares Non Current
LiabilityToIssueSharesNonCurrent
1527153
CY2023Q3 muln Liability To Issue Shares Non Current
LiabilityToIssueSharesNonCurrent
1827889
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9230806
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3566922
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2165062
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3891900
CY2023Q4 us-gaap Liabilities
Liabilities
109362423
CY2023Q3 us-gaap Liabilities
Liabilities
148897620
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5884691
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5884691
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2871707
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2871707
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5885
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2872
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2134106479
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2071110126
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1923556935
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1862162037
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
210557005
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
208952537
CY2022Q4 muln Stock Issued During Period Value Surplus On Cashless Warrant Exercise
StockIssuedDuringPeriodValueSurplusOnCashlessWarrantExercise
26735478
CY2022Q4 muln Stock Issued During Period Conversion Of Common Stock Into Preferred Stock Value
StockIssuedDuringPeriodConversionOfCommonStockIntoPreferredStockValue
0
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-3122227
CY2022Q4 muln Stock Issued During Period Value Notes Payable Settlement
StockIssuedDuringPeriodValueNotesPayableSettlement
13736403
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
59402876
CY2023Q4 us-gaap Minority Interest
MinorityInterest
61257092
CY2023Q3 us-gaap Minority Interest
MinorityInterest
63855573
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
271814097
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
272808110
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381176520
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
421705730
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43234052
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64996011
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16169967
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8622009
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-59404019
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-73618020
CY2022Q4 muln Other Financing Cost On Initial Recognition Of Derivative Liabilities
OtherFinancingCostOnInitialRecognitionOfDerivativeLiabilities
255960025
CY2023Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-6728981
CY2022Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-40781976
CY2022Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6412170
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
75990
CY2023Q4 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
50000
CY2023Q4 us-gaap Financing Interest Expense
FinancingInterestExpense
258023
CY2022Q4 us-gaap Financing Interest Expense
FinancingInterestExpense
2828089
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
545416
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
645881
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65719617
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-378954399
CY2023Q4 muln Income Tax Expense Benefit Income Statement
IncomeTaxExpenseBenefitIncomeStatement
-1726238
CY2022Q4 muln Income Tax Expense Benefit Income Statement
IncomeTaxExpenseBenefitIncomeStatement
-493654
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-63993379
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-378460745
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2598481
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2184959
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-61394898
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-376275786
CY2023Q4 muln Preferred Stock Dividends And Adjustments Income Statement Impact
PreferredStockDividendsAndAdjustmentsIncomeStatementImpact
21303
CY2022Q4 muln Preferred Stock Dividends And Adjustments Income Statement Impact
PreferredStockDividendsAndAdjustmentsIncomeStatementImpact
638677
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61416201
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-376914463
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.32
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15.32
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6233.08
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6233.08
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4007791
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4007791
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60470
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60470
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
156956709
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
30267660
CY2022Q4 muln Stock Issued During Period Value Penalty To Shareholders
StockIssuedDuringPeriodValuePenaltyToShareholders
5520000
CY2022Q4 muln Stock Issued During Period Value Cashless Warrant Exercise
StockIssuedDuringPeriodValueCashlessWarrantExercise
110327241
CY2022Q4 muln Adjustments To Additional Paid In Capital Preferred Shares Issued To Officers
AdjustmentsToAdditionalPaidInCapitalPreferredSharesIssuedToOfficers
25000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
638677
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2184959
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-376275786
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20749719
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
272808110
CY2023Q4 muln Stock Issued During Period Value Cashless Warrant Exercise
StockIssuedDuringPeriodValueCashlessWarrantExercise
50877669
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12143000
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
21303
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2598481
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-61394898
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
271814097
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-63993379
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-378460745
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
13903416
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
40753410
CY2023Q4 muln Revaluation Of Derivative Liabilities
RevaluationOfDerivativeLiabilities
6728981
CY2022Q4 muln Revaluation Of Derivative Liabilities
RevaluationOfDerivativeLiabilities
40781976
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4343960
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4794327
CY2023Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
160664
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
74577
CY2023Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1726238
CY2022Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
493654
CY2023Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
125990
CY2022Q4 muln Other Financing Cost On Initial Recognition Of Derivative Liabilities
OtherFinancingCostOnInitialRecognitionOfDerivativeLiabilities
255960025
CY2022Q4 muln Loss Gain On Revaluation Of Derivatives
LossGainOnRevaluationOfDerivatives
-9965728
CY2022Q4 muln Financing Gain Loss On Warrants
FinancingGainLossOnWarrants
-8934892
CY2022Q4 muln Gain Loss On Extinguishment Of Debt And Incentive Fee Expense
GainLossOnExtinguishmentOfDebtAndIncentiveFeeExpense
-6412171
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-671750
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13912516
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1781132
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8457324
CY2023Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1317232
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
7724852
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3044392
CY2022Q4 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1576292
CY2023Q4 muln Increase Decrease In Right Of Use Assets And Lease Liabilities
IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilities
2433909
CY2022Q4 muln Increase Decrease In Right Of Use Assets And Lease Liabilities
IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilities
-289821
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59891553
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33227692
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6865681
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
726482
CY2022Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
74826
CY2022Q4 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
92916874
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6865681
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93718182
CY2022Q4 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
150000000
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66757234
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23054126
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
429372
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155696470
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84375085
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7426972
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88939236
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107429211
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
3056
CY2023Q4 muln Exercise Of Warrants Recognized Earlier As Liabilities
ExerciseOfWarrantsRecognizedEarlierAsLiabilities
50877669
CY2022Q4 muln Exercise Of Warrants Recognized Earlier As Liabilities
ExerciseOfWarrantsRecognizedEarlierAsLiabilities
84799179
CY2023Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8932159
CY2022Q4 muln Convertible Notes Conversion To Stock
ConvertibleNotesConversionToStock
59402877
CY2022Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1096787
CY2023Q4 muln Stock Issued During Period Fractional Shares Stock Splits
StockIssuedDuringPeriodFractionalSharesStockSplits
0
CY2023Q4 muln Stock Issued During Period Shares To Avoid Fractional Shares On Reverse Stock Splits
StockIssuedDuringPeriodSharesToAvoidFractionalSharesOnReverseStockSplits
321036
CY2022Q3 muln Stockholders Equity Note Reverse Stock Split Transaction
StockholdersEquityNoteReverseStockSplitTransaction
833431
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88900000
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59900000
CY2023Q4 muln Net Working Capital
NetWorkingCapital
47100000
CY2023Q4 muln Working Capital Excluding Derivative Liabilities
WorkingCapitalExcludingDerivativeLiabilities
79300000
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-64000000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1923600000
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of our financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the dates of the consolidated condensed financial statements and the reported amounts of total expenses in the reporting periods. Estimates are used for, but not limited to, cash flow projections and discount rate for calculation of goodwill impairment, fair value and impairment of long-lived assets, including intangible assets, inventory reserves, accrued expenses, fair value of financial instruments, depreciable lives of property and equipment, income taxes, contingencies, valuation of preferred stock and warrants. Additionally, the rates of interest on several debt agreements have been imputed where there was no stated interest rate within the original agreement. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for carrying values of assets and liabilities and the recording of costs and expenses that are not readily apparent from other sources. The actual results may differ materially from these estimates.</p>
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
7000000
CY2023Q4 muln Refundable Deposits
RefundableDeposits
429000
CY2023Q4 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Concentrations of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains cash balances in several financial institutions that are insured by either the Federal Deposit Insurance Corporation or the National Credit Union Association up to certain federal limitations, generally $250,000. At times, our cash balance may exceed these federal limitations. However, we have not experienced any losses in such accounts and management believes we are not exposed to any significant credit risk on these accounts. The amounts in excess of insured limits as of December 31, 2023 and September 30, 2023 are $87.8 million and $154.9 million, respectively. </p>
CY2023Q4 us-gaap Time Deposit Liability Above Us Insurance Limit
TimeDepositLiabilityAboveUsInsuranceLimit
87800000
CY2023Q3 us-gaap Time Deposit Liability Above Us Insurance Limit
TimeDepositLiabilityAboveUsInsuranceLimit
154900000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4010456
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
3136590
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
18524512
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
13733385
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
226009
CY2023Q4 muln Finished Goods Delivered To Dealer For Distribution
FinishedGoodsDeliveredToDealerForDistribution
7958552
CY2023Q3 muln Finished Goods Delivered To Dealer For Distribution
FinishedGoodsDeliveredToDealerForDistribution
937322
CY2023Q3 us-gaap Inventory Adjustments
InventoryAdjustments
1000284
CY2023Q4 us-gaap Inventory Net
InventoryNet
30719529
CY2023Q3 us-gaap Inventory Net
InventoryNet
16807013
CY2023Q4 muln Inventory Consumed For Research And Development Activities
InventoryConsumedForResearchAndDevelopmentActivities
65000
CY2023Q4 us-gaap Goodwill
Goodwill
28846832
CY2023Q3 us-gaap Goodwill
Goodwill
28846832
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
63988000
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
50489431
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5224116
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45265315
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
49834877
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3904240
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45930637
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58304612
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58304612
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58304612
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58304612
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
108794043
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5224116
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
103569927
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
108139489
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3904240
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
104235249
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3930834
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5250711
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5250711
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5240901
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5110712
CY2023Q4 muln Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
20481446
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45265315
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1319877
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2756704
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
109525
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
109525
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
7622156
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7622156
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
270189
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
270189
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
7461492
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7461492
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
7622156
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
7622156
CY2023Q4 muln Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
1617759
CY2023Q3 muln Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
1548723
CY2022Q3 muln Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
35000000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.4379
CY2022Q3 muln Class Of Warrant Exercise Price Of Warrants After Reverse Stock Split
ClassOfWarrantExercisePriceOfWarrantsAfterReverseStockSplit
9853
CY2022Q3 muln Warrant Exercised Cash Less
WarrantExercisedCashLess
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
64863309
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
6728980
CY2023Q4 muln Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfWarrants
50877669
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
20714620
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
84799179
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
244510164
CY2022Q4 muln Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Derivative Liability Upon Authorized Shares Shortfall
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityDerivativeLiabilityUponAuthorizedSharesShortfall
11978167
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
40781976
CY2022Q4 muln Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassifications
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications
10183443
CY2022Q4 muln Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Financing Loss Upon Over Issuance Of Shares From Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityFinancingLossUponOverIssuanceOfSharesFromWarrants
-8934892
CY2022Q4 muln Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Receivables Upon Over Issuance Of Shares From Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReceivablesUponOverIssuanceOfSharesFromWarrants
17721868
CY2022Q4 muln Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfWarrants
137062719
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
261480084
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1750000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5884691
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2871707
CY2023Q4 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2023Q4 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 muln Minimum Term Of Shares Issued And Outstanding
MinimumTermOfSharesIssuedAndOutstanding
P1Y
CY2023Q4 muln Preferred Stock Redemption Number Of Trading Days
PreferredStockRedemptionNumberOfTradingDays
20
CY2023Q4 muln Preferred Stock Redemption Number Of Consecutive Trading Days
PreferredStockRedemptionNumberOfConsecutiveTradingDays
30
CY2023Q4 muln Number Of Vote Per Share
NumberOfVotePerShare
1000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-61394898
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-376275786
CY2023Q4 muln Preferred Stock Dividends And Adjustments Income Statement Impact
PreferredStockDividendsAndAdjustmentsIncomeStatementImpact
21303
CY2022Q4 muln Preferred Stock Dividends And Adjustments Income Statement Impact
PreferredStockDividendsAndAdjustmentsIncomeStatementImpact
638677
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61416201
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-376914463
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.32
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6233.08
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4007791
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60470
CY2023Q4 muln Share Based Payment Arrangement Expense For Share Issuance
ShareBasedPaymentArrangementExpenseForShareIssuance
2161387
CY2022Q4 muln Share Based Payment Arrangement Expense For Share Issuance
ShareBasedPaymentArrangementExpenseForShareIssuance
36376972
CY2023Q4 muln Share Based Compensation To Consultants Equity Classified
ShareBasedCompensationToConsultantsEquityClassified
1066548
CY2022Q4 muln Share Based Compensation To Consultants Equity Classified
ShareBasedCompensationToConsultantsEquityClassified
2642074
CY2023Q4 muln Share Based Compensation To Consultants Liability Classified
ShareBasedCompensationToConsultantsLiabilityClassified
10675481
CY2022Q4 muln Share Based Compensation To Consultants Liability Classified
ShareBasedCompensationToConsultantsLiabilityClassified
1734364
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13903416
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40753410
CY2023Q4 muln Provision For Penalties And Settlements Current
ProvisionForPenaltiesAndSettlementsCurrent
26392247
CY2023Q3 muln Provision For Penalties And Settlements Current
ProvisionForPenaltiesAndSettlementsCurrent
27800000
CY2023Q4 muln Accrued Accounts Payable Current
AccruedAccountsPayableCurrent
3228426
CY2023Q3 muln Accrued Accounts Payable Current
AccruedAccountsPayableCurrent
2964864
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2186436
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2849346
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2102931
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2406650
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1617759
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1548724
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
611853
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
868495
CY2023Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
652200
CY2023Q3 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
652200
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1375085
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2111650
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38166937
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41201929
CY2023Q4 muln Liability To Issue Shares Current
LiabilityToIssueSharesCurrent
11500000
CY2023Q4 muln Liability To Issue Shares Non Current
LiabilityToIssueSharesNonCurrent
1500000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
94895567
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
86988028
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7979326
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4955243
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86916241
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82032785
CY2023Q4 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2023Q4 us-gaap Depreciation
Depreciation
3024083
CY2022Q4 us-gaap Depreciation
Depreciation
2037623
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6686868
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8850311
CY2023Q4 muln Prepaid Trade Shows Current
PrepaidTradeShowsCurrent
3779338
CY2023Q3 muln Prepaid Trade Shows Current
PrepaidTradeShowsCurrent
2731352
CY2023Q4 muln Prepaid Services Current
PrepaidServicesCurrent
4606224
CY2023Q3 muln Prepaid Services Current
PrepaidServicesCurrent
6041111
CY2023Q4 us-gaap Supplies
Supplies
2813722
CY2023Q3 us-gaap Supplies
Supplies
5063965
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1961227
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2025154
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
730833
CY2023Q3 us-gaap Prepaid Rent
PrepaidRent
47215
CY2023Q4 muln Prepaid Retainer Current
PrepaidRetainerCurrent
685243
CY2023Q3 muln Prepaid Retainer Current
PrepaidRetainerCurrent
196115
CY2023Q4 muln Customs Surety Bond Current
CustomsSuretyBondCurrent
2600000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23863455
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24955223
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
16220998
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
8652777
CY2023Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7227842
CY2022Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
44142360
CY2023Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
6341015
CY2022Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2968234
CY2023Q4 us-gaap Depreciation Nonproduction
DepreciationNonproduction
3024083
CY2022Q4 us-gaap Depreciation Nonproduction
DepreciationNonproduction
4388355
CY2023Q4 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1319877
CY2022Q4 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
405972
CY2023Q4 muln Employee Benefits
EmployeeBenefits
1879490
CY2022Q4 muln Employee Benefits
EmployeeBenefits
1033638
CY2023Q4 us-gaap Utilities Operating Expense Operations
UtilitiesOperatingExpenseOperations
1584456
CY2022Q4 us-gaap Utilities Operating Expense Operations
UtilitiesOperatingExpenseOperations
255039
CY2023Q4 muln Listing And Regulatory Fees
ListingAndRegulatoryFees
1491707
CY2022Q4 muln Listing And Regulatory Fees
ListingAndRegulatoryFees
1301844
CY2023Q4 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
823234
CY2022Q4 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
181239
CY2023Q4 muln Settlements And Penalties
SettlementsAndPenalties
1911664
CY2022Q4 muln Settlements And Penalties
SettlementsAndPenalties
20844
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
198485
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
831090
CY2023Q4 muln Executive Expenses And Directors Fees
ExecutiveExpensesAndDirectorsFees
284362
CY2022Q4 muln Executive Expenses And Directors Fees
ExecutiveExpensesAndDirectorsFees
209044
CY2023Q4 us-gaap Other General Expense
OtherGeneralExpense
926839
CY2022Q4 us-gaap Other General Expense
OtherGeneralExpense
605575
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43234052
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64996011
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16169967
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8622009
CY2023Q4 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q4 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13400598
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5249417
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2137882
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2134494
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9230806
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3566922
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11368688
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5701416
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M25D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y11M23D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.28
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.28
CY2023Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
1316045
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
771771
CY2023Q4 us-gaap Variable Lease Cost
VariableLeaseCost
56696
CY2022Q4 us-gaap Variable Lease Cost
VariableLeaseCost
31288
CY2023Q4 us-gaap Sublease Income
SubleaseIncome
167163
CY2022Q4 us-gaap Sublease Income
SubleaseIncome
63857
CY2023Q4 us-gaap Lease Cost
LeaseCost
1205578
CY2022Q4 us-gaap Lease Cost
LeaseCost
739202
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2276166
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5498855
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4044143
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3962569
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3728589
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1874007
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
21384329
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10015641
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11368688
CY2023Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
18000000
CY2023Q4 muln Reclassification Of Settlement Liabilities To Notes Payable
ReclassificationOfSettlementLiabilitiesToNotesPayable
18000000
CY2023Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-001064-index-headers.html Edgar Link pending
0001558370-24-001064-index.html Edgar Link pending
0001558370-24-001064.txt Edgar Link pending
0001558370-24-001064-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
muln-20231231.xsd Edgar Link pending
muln-20231231x10q.htm Edgar Link pending
muln-20231231xex31d1.htm Edgar Link pending
muln-20231231xex31d2.htm Edgar Link pending
muln-20231231xex32d1.htm Edgar Link pending
muln-20231231_cal.xml Edgar Link unprocessable
muln-20231231_def.xml Edgar Link unprocessable
muln-20231231_lab.xml Edgar Link unprocessable
muln-20231231x10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
muln-20231231_pre.xml Edgar Link unprocessable